Retraction
Tim-3 expression in cervical cancer promotes tumor metastasis
Paper Information
Record ID:
64880
Author(s):
Publication Date:
January 15, 2013
Retraction Date:
July 25, 2024
(1.3 year years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0308113Citations (141)
141
Total Citations5
Post-Retraction(3.5%)
135
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
5
Within 1 year
0
After 2+ years
251
Days since retraction (latest)
Immune checkpoints regulate acute myeloid leukemia stem cells
C. Bachmann, Adrian F. Ochsenbein
Leukemia
Open Access
Published: Apr 2025
3 citations
3 citations
251 days after retraction
Paper citing Tim-3 expression in cervical cancer promotes tumor...
Unknown Authors
Unknown Journal
Published: Mar 2025
238 days after retraction
Overcoming the novel glycan-lectin checkpoints in tumor microenvironment for the success of the cross-presentation-based immunotherapy
Mannat Jain, Isha M. Jadhav, Suyash Vinayak Dangat et al. (7 authors)
Biomaterials Science
Open Access
Published: Jan 2025
160 days after retraction
The role of Tim-3 blockade in the tumor immune microenvironment beyond T cells
Jie Zhang, Longsheng Wang, Hongjie Guo et al. (8 authors)
Pharmacological Research
Open Access
Published: Oct 2024
9 citations
9 citations
78 days after retraction
Transforming growth factor-β micro-environment mediated immune cell functions in cervical cancer
Jayapradha Gnanagurusamy, Sneha Krishnamoorthy, Sridhar Muthusami
International Immunopharmacology
Published: Aug 2024
5 citations
5 citations
13 days after retraction
Retraction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
Unknown Authors
PLoS ONE
Open Access
Published: Jul 2024
Same day as retraction
TIM-3/CD68 double-high expression in Glioma: Prognostic characteristics and potential therapeutic approaches
Wanming Hu, De‐Pei Li, Yuanzhong Yang et al. (6 authors)
International Immunopharmacology
Published: Jul 2024
3 citations
3 citations
13 days before retraction
The effects of HIV and oncogenic human papillomavirus on the tumor immune microenvironment of penile squamous cell carcinoma
Chibamba Mumba, Zoran Muhimbe, Victor Mapulanga et al. (9 authors)
PLoS ONE
Open Access
Published: May 2024
4 citations
4 citations
85 days before retraction
<scp>CircPVT1</scp> promotes migration and invasion by regulating <scp>miR</scp>‐490‐5p/<scp><i>HAVCR2</i></scp> axis in osteosarcoma cells
Chunbin Zhou, Lois Balmer, Manshu Song et al. (6 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Apr 2024
4 citations
4 citations
115 days before retraction
The Role of Immune Check Point Gene Expression of Pd-1 and Tim-3 in Patients with Acute Myeloid Leukemia
Sara Mohammed Oudah, Israa Hussein Hamzah, Bassam Francis Matti
Al-Mustansiriyah Journal of Science
Open Access
Published: Mar 2024
1 citation
1 citation
117 days before retraction
Immune сheckpoints in the context of external genital endometriosis
A. S. Belevich, Maria I. Yarmolinskaya, S. А. Selkov et al. (4 authors)
Medical Immunology (Russia)
Open Access
Published: Mar 2024
140 days before retraction
Other Immune Checkpoint Targets of Interest
Clifford M. Csizmar, Stephen M. Ansell
Unknown Journal
Published: Feb 2024
155 days before retraction
Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined the party
Chenyu Lu, Yuanyan Tan
Deleted Journal
Open Access
Published: Feb 2024
29 citations
29 citations
164 days before retraction
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers
S Mestiri, Dina Moustafa Abo El-Ella, Queenie Fernandes et al. (15 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jan 2024
11 citations
11 citations
201 days before retraction
Pan‐cancer analysis of <scp>TIM</scp>‐3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity
Jungah Lim, Razelle Kurzrock, Daisuke Nishizaki et al. (12 authors)
Cancer Medicine
Open Access
Published: Dec 2023
7 citations
7 citations
216 days before retraction
TIM-3 regulates the proliferation by BDNF-mediated PI3K/AKT axis in the process of endometriosis
Wei Tian, Min Liu, Yuqiu Liu et al. (7 authors)
Molecular Medicine
Open Access
Published: Dec 2023
3 citations
3 citations
219 days before retraction
Immuno-Oncology In Cancer Cervix Treatments: Literature Review
Maged Naser, Mohamed Nasr, Lamia H. Shehata
International Journal of Progressive Sciences and Technologies
Open Access
Published: Oct 2023
1 citation
1 citation
269 days before retraction
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
Dia Roy, Cassandra Gilmour, Sachin Patnaik et al. (4 authors)
Frontiers in Immunology
Open Access
Published: Oct 2023
29 citations
29 citations
280 days before retraction
Expression of <scp>B7‐H3</scp> and <scp>TIM</scp>‐3 in gastric‐type endocervical adenocarcinoma: prevalence, association with <scp>PD‐L1</scp> expression, and prognostic significance
Yao Sun, Xin Zhou, Elena Lucas et al. (7 authors)
The Journal of Pathology Clinical Research
Open Access
Published: Oct 2023
2 citations
2 citations
294 days before retraction
Upregulated HAVCR2: A Prognostic and Immune-Related Marker in Testicular Germ Cell Tumors
Lei Xue, Xueheng Zhao, Hanbo Jia et al. (11 authors)
Andrologia
Open Access
Published: Sep 2023
2 citations
2 citations
308 days before retraction
Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review
Ranferi Ocaña‐Guzmán, Diego Osorio-Pérez, Leslie Chávez‐Galán
Pharmaceuticals
Open Access
Published: Aug 2023
1 citation
1 citation
351 days before retraction
Role of Tim-3 in COVID-19: a potential biomarker and therapeutic target
Haodong Ma, Shengju Ren, Qingpeng Meng et al. (9 authors)
Archives of Virology
Published: Jul 2023
3 citations
3 citations
360 days before retraction
The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review
Luc Ollivier, Camille Moreau Bachelard, Emmanuelle Renaud et al. (5 authors)
Frontiers in Immunology
Open Access
Published: Jul 2023
6 citations
6 citations
372 days before retraction
Clinicopathological and prognostic significance of PD-L1 and TIM-3 expression in medullary thyroid carcinoma: a retrospective immunohistochemistry study
Dilinaer Wusiman, Lei Guo, Ling Li et al. (13 authors)
Journal of Endocrinological Investigation
Open Access
Published: Jul 2023
6 citations
6 citations
373 days before retraction
The future of combination immunotherapy in oesophageal adenocarcinoma
Maria Davern, Noel E. Donlon
Frontiers in Immunology
Open Access
Published: Jul 2023
1 citation
1 citation
377 days before retraction
Current Methods and Advances in the Immunotherapy Treatment of Non-Ovarian Gynaecological Cancers
Sola Adeleke, Yujia Gao, Somto Okoli et al. (7 authors)
Future Pharmacology
Open Access
Published: Jun 2023
420 days before retraction
Tim3 and PD-1 as a therapeutic and prognostic targets in colorectal cancer: Relationship with sidedness, clinicopathological parameters, and survival
Zahra Mokhtari, Marzieh Rezaei, Mohammad Hossein Sanei et al. (7 authors)
Frontiers in Oncology
Open Access
Published: Mar 2023
13 citations
13 citations
490 days before retraction
The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
Florian N. Loch, Carsten Kamphues, Katharina Beyer et al. (9 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2023
7 citations
7 citations
551 days before retraction
Pan-cancer analysis to provide a reliable basis for the clinical use of TIM-3 immunosuppressants
Bangqian Mo, Yongfeng Wang, Deming Liu et al. (4 authors)
Research Square (Research Square)
Open Access
Published: Jan 2023
561 days before retraction
Immunotherapy for Cervical Cancer
Adriana Gutiérrez‐Hoya, Arturo Valle‐Mendiola, Isabel Soto‐Cruz
Springer eBooks
Published: Jan 2023
571 days before retraction
Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
Zhengwei Wu, Jiawang Ou, Nannan Liu et al. (10 authors)
Cancer Medicine
Open Access
Published: Dec 2022
17 citations
17 citations
582 days before retraction
Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer
Paweł Łaniewski, Haiyan Cui, Nichole D. Mahnert et al. (9 authors)
Biomarker Research
Open Access
Published: Dec 2022
8 citations
8 citations
601 days before retraction
Advanced Acral Melanoma Therapies: Current Status and Future Directions
Yiqun Zhang, Shijie Lan, Di Wu
Current Treatment Options in Oncology
Open Access
Published: Sep 2022
21 citations
21 citations
674 days before retraction
Recurrent or primary metastatic cervical cancer: current and future treatments
Christine Gennigens, Guy Jérusalem, L. Lapaille et al. (7 authors)
ESMO Open
Open Access
Published: Sep 2022
90 citations
90 citations
681 days before retraction
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
Jordan W. Conway, Robert V. Rawson, Serigne Lo et al. (18 authors)
Journal for ImmunoTherapy of Cancer
Open Access
Published: Sep 2022
40 citations
40 citations
693 days before retraction
The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition
A. Yu. Kuzevanova, Н. В. Апанович, Danzan Mansorunov et al. (5 authors)
Biomedicines
Open Access
Published: Aug 2022
8 citations
8 citations
700 days before retraction
Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy
Hetong Li, Dinglong Yang, Min Hao et al. (4 authors)
Frontiers in Genetics
Open Access
Published: Aug 2022
16 citations
16 citations
702 days before retraction
Inhibition of Melanoma Cell–Intrinsic Tim-3 Stimulates MAPK-Dependent Tumorigenesis
Tobias Schatton, Yuta Itoh, Christina Martins et al. (21 authors)
Cancer Research
Open Access
Published: Aug 2022
17 citations
17 citations
707 days before retraction
Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients
Alhasan Alsalman, Mohammad A. Al-Mterin, Khaled Murshed et al. (7 authors)
Cancers
Open Access
Published: Jun 2022
14 citations
14 citations
757 days before retraction
Analysis of possible markers of effective antitumor cellular immune response before starting therapy with immune check-point inhibitors
Анна Малкова, R. V. Orlova, Natalia V. Zhukova et al. (5 authors)
Siberian Journal of Oncology
Open Access
Published: May 2022
809 days before retraction
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours
Maria Davern, Marie-Claire Fitzgerald, Croí E. Buckley et al. (16 authors)
Translational Oncology
Open Access
Published: Mar 2022
6 citations
6 citations
877 days before retraction
PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma
Maria Davern, Rebecca M. O’ Brien, Jason McGrath et al. (11 authors)
Scientific Reports
Open Access
Published: Feb 2022
7 citations
7 citations
878 days before retraction
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors
Ana Luiza Gomes de Morais, Sara Sirvent Cerdá, Maria J. de Miguel
Current Oncology Reports
Published: Feb 2022
50 citations
50 citations
880 days before retraction
Clinical Significance of Expression of Immunoadjuvant Molecules (LAG-3, TIM-3, OX-40) in Neoadjuvant Chemotherapy for Breast Cancer
Yuka Asano, Shinichiro Kashiwagi, Koji Takada et al. (10 authors)
Anticancer Research
Open Access
Published: Dec 2021
9 citations
9 citations
939 days before retraction
PD-1 immune checkpoint blockade enhances FLOT chemotherapy toxicity in oesophageal adenocarcinoma cells via immune-independent mechanisms
Maria Davern, Rebecca M. O’ Brien, Jason McGrath et al. (11 authors)
Research Square (Research Square)
Open Access
Published: Oct 2021
1004 days before retraction
Clinical Value of Combined Detection of Serum sTim-3 and Pepsinogen for Gastric Cancer Diagnosis
Lingli Chen, Jianfeng Hong, Renjing Hu et al. (13 authors)
Cancer Management and Research
Open Access
Published: Oct 2021
12 citations
12 citations
1028 days before retraction
The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives
Robert J. Walsh, David S.P. Tan
Journal of Clinical Medicine
Open Access
Published: Sep 2021
18 citations
18 citations
1030 days before retraction
Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
Tian Tian, Zhaoming Li
Frontiers in Oncology
Open Access
Published: Sep 2021
74 citations
74 citations
1037 days before retraction
Modern possibilities of using immunotherapy in the treatment of cervical cancer
Anna V. Tarasova, K. А. Ganina, M. А. Meshkova et al. (6 authors)
Tumors of female reproductive system
Open Access
Published: Sep 2021
1039 days before retraction
Tumor-Derived Exosomes: Hidden Players in PD-1/PD-L1 Resistance
Valentin Vautrot, Hafidha Bentayeb, Sébastien Causse et al. (5 authors)
Cancers
Open Access
Published: Sep 2021
36 citations
36 citations
1049 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #64882
Mar 29, 2016Quick Stats
Total Citations:
141
Years Since Retraction:
1.3 year
Open Access:
Yes
Last Checked:
Jul 24, 2025